Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inhibition of platelet aggregation].

Thomas C Wascher1

  • 1Medizinische Universitätsklinik Graz, Graz, Osterreich. thomas.wascher@meduni-graz.at

Acta Medica Austriaca
|March 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

[Diagnostics and treatment of type 1 diabetes mellitus (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

[Obesity and type 2 diabetes mellitus (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

[Lipids - Diagnostics and treatment in diabetes mellitus (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

[Cardiovascular diseases and heart failure in diabetes: diagnostics and management (Update 2026)].

Wiener klinische Wochenschrift·2026
Same author

Intrahospital Prevalence of Diabetes and Prediabetes in Medical Departments in Upper Austria.

Journal of clinical medicine·2025
Same journal

[Gestational diabetes mellitus].

Acta medica Austriaca·2005
Same journal

[Diagnosis, therapy and follow-up of diabetic eye diseases].

Acta medica Austriaca·2005
Same journal

[Diabetic nephropathy].

Acta medica Austriaca·2005
Same journal

[The diabetic foot].

Acta medica Austriaca·2005
Same journal

[Diabetic neuropathy].

Acta medica Austriaca·2005
Same journal

[Lipids--diagnosis and therapy in type 2 diabetes].

Acta medica Austriaca·2005
See all related articles

Diabetic patients face higher risks of acute atherothrombotic events. Antiplatelet drugs can help prevent these cardiovascular complications by inhibiting platelet aggregation, according to new guidelines.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Context:

  • Accelerated atherosclerosis is a significant concern in diabetic patients, leading to increased cardiovascular morbidity and mortality.
  • Acute atherothrombotic events are a major cause of death in individuals with diabetes.

Purpose:

  • To provide evidence-based recommendations for the use of antiplatelet drugs in diabetic patients.
  • To outline strategies for reducing the risk of acute atherothrombosis in this population.

Summary:

  • Inhibition of platelet aggregation is a key strategy to mitigate the risk of acute atherothrombosis.
  • The Austrian Diabetes Association has developed guidelines for antiplatelet therapy in diabetic individuals.
  • Recommendations are based on current scientific evidence regarding antiplatelet drug efficacy and safety.

Related Experiment Videos

Impact:

  • Improved cardiovascular outcomes for diabetic patients.
  • Reduced incidence of atherothrombotic events and associated mortality.
  • Standardized approach to antiplatelet therapy in diabetes management.